Literature DB >> 17989156

Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease.

Evans R Fernández-Pérez1, Murat Yilmaz, Hussam Jenad, Craig E Daniels, Jay H Ryu, Rolf D Hubmayr, Ognjen Gajic.   

Abstract

BACKGROUND: While patients with interstitial lung disease (ILD) may be particularly susceptible to ventilator-induced lung injury, ventilator strategies have not been studied in this group of patients. PURPOSES: To describe the clinical course and outcome of patients with ILD and acute respiratory failure in relation to ventilatory parameters.
METHODS: We retrospectively identified a cohort of ventilated patients with ILD who had been admitted to five ICUs at a single institution. We analyzed demographic data, pulmonary function test results, severity of illness, and the parameters of continuous ventilation for the initial 24 h after admission to the ICU. Primary outcomes were survival to hospital discharge and 1-year survival. MAIN
RESULTS: Of 94 patients with ILD, 44 (47%) survived to hospital discharge and 39 (41%) were alive at 1 year. Nonsurvivors were less likely to be postoperative, had higher severity of illness, and were ventilated at higher airway pressures and lower tidal volumes. Step changes in positive end-expiratory pressure (PEEP) of > 10 cm H(2)O were attempted in 20 patients and resulted in an increase in plateau pressure (median difference, + 16 cm H(2)O; interquartile range [IQR], 9 to 24 cm H(2)O) and a decrease in respiratory system compliance (median difference, - 0.28 mL/kg/cm H(2)O; IQR, - 0.43 to - 0.13 mL/kg/cm H(2)O). The Cox proportional hazards model revealed that high PEEP (hazard ratio, 4.72; 95% confidence interval [CI], 2.06 to 11.15), acute physiology and chronic health evaluation (APACHE) III score predicted mortality (hazard ratio 1.33; 95% CI, 1.18 to 1.50), age (hazard ratio, 1.03; 95% CI, 1 to 1.05), and low Pao(2)/fraction of inspired oxygen ratio (hazard ratio, 0.96; 95% CI, 0.92 to 0.99) to be independent determinants of survival.
CONCLUSION: Both severity of illness and high PEEP settings are associated with the decreased survival of patients with ILD who are receiving mechanical ventilation.

Entities:  

Mesh:

Year:  2007        PMID: 17989156      PMCID: PMC4003484          DOI: 10.1378/chest.07-1481

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  29 in total

Review 1.  International consensus conferences in intensive care medicine. Ventilator-associated lung injury in ARDS. American Thoracic Society, European Society of Intensive Care Medicine, Societé de Réanimation Langue Française.

Authors: 
Journal:  Intensive Care Med       Date:  1999-12       Impact factor: 17.440

2.  ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias.

Authors:  M Demedts; U Costabel
Journal:  Eur Respir J       Date:  2002-05       Impact factor: 16.671

3.  Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias.

Authors:  Andrew Churg; Nestor L Müller; C Isabela S Silva; Joanne L Wright
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

4.  Surgical resection of lung cancer in patients with underlying interstitial lung disease.

Authors:  Emmanuel Martinod; Jacques F Azorin; Danielle Sadoun; Marie-Dominique Destable; Philippe Le Toumelin; Elisabeth Longchampt; Marianne Kambouchner; Loïc Guillevin; Dominique Valeyre
Journal:  Ann Thorac Surg       Date:  2002-10       Impact factor: 4.330

5.  Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program.

Authors:  A M Arozullah; J Daley; W G Henderson; S F Khuri
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

6.  Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis.

Authors:  T Fumeaux; C Rothmeier; P Jolliet
Journal:  Intensive Care Med       Date:  2001-10-31       Impact factor: 17.440

7.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

8.  Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure.

Authors:  J B Stern; H Mal; O Groussard; O Brugière; A Marceau; G Jebrak; M Fournier
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

9.  Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure.

Authors:  S Blivet; F Philit; J M Sab; B Langevin; M Paret; C Guérin; D Robert
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

10.  Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit.

Authors:  Ghulam Saydain; Ashiq Islam; Bekele Afessa; Jay H Ryu; John P Scott; Steve G Peters
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

View more
  42 in total

1.  Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.

Authors:  Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc
Journal:  Am J Respir Crit Care Med       Date:  2010-08-27       Impact factor: 21.405

2.  [Acute on chronic respiratory failure in interstitial pneumonias].

Authors:  M Westhoff
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-08-16       Impact factor: 0.840

3.  Palliative care and location of death in decedents with idiopathic pulmonary fibrosis.

Authors:  Kathleen O Lindell; Zhan Liang; Leslie A Hoffman; Margaret Q Rosenzweig; Melissa I Saul; Joseph M Pilewski; Kevin F Gibson; Naftali Kaminski
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

4.  Extracorporeal membrane oxygenation for interstitial lung disease: what is on the other side of the bridge?

Authors:  Sacha Rozencwajg; Matthieu Schmidt
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

5.  Decision support tool for early differential diagnosis of acute lung injury and cardiogenic pulmonary edema in medical critically ill patients.

Authors:  Christopher N Schmickl; Khurram Shahjehan; Guangxi Li; Rajanigandha Dhokarh; Rahul Kashyap; Christopher Janish; Anas Alsara; Allan S Jaffe; Rolf D Hubmayr; Ognjen Gajic
Journal:  Chest       Date:  2011-10-26       Impact factor: 9.410

6.  [Extracorporeal membrane oxygenation for treatment of acute respiratory failure : Outcome of patients with interstitial lung disease].

Authors:  F C Trudzinski; P M Lepper
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-08-15       Impact factor: 0.840

Review 7.  Brazilian recommendations of mechanical ventilation 2013. Part 2.

Authors: 
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

Review 8.  Biofabrication of phenotypic pulmonary fibrosis assays.

Authors:  Cameron Yamanishi; Stephen Robinson; Shuichi Takayama
Journal:  Biofabrication       Date:  2019-06-19       Impact factor: 9.954

Review 9.  Contemporary approaches in the use of extracorporeal membrane oxygenation to support patients waiting for lung transplantation.

Authors:  Steven P Keller
Journal:  Ann Cardiothorac Surg       Date:  2020-01

10.  Interstitial lung abnormality is prevalent and associated with worse outcome in patients undergoing transcatheter aortic valve replacement.

Authors:  Michael Kadoch; Aleksandar Kitich; Shehabaldin Alqalyoobi; Elyse Lafond; Elena Foster; Maya Juarez; Cesar Mendez; Thomas W Smith; Garrett Wong; Walter D Boyd; Jeffrey Southard; Justin M Oldham
Journal:  Respir Med       Date:  2018-02-27       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.